Loading company…
Synthetica develops live bacterial drugs for solid tumor treatment.
Synthetica researches and develops oncolytic bacteria and live bacterial drugs for solid tumor treatment using synthetic biology. Established in 2023, the company is based in Shenzhen, China. In July 2024, it closed a strategic investment from Boehringer Ingelheim Venture, Lenovo Venture Capital, Fosun Health Capital, and Summer Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in